-
Investors Should Own Agios For 'The Next Several Years,' Analyst Says
Thursday, May 31, 2018 - 4:04pm | 385Read More...Agios Pharmaceuticals Inc (NASDAQ: AGIO), a pharmaceutical company that focuses on the field cellular metabolism to treat cancer and rare genetic diseases, is a stock investors should "own for the next several years," according to Piper Jaffray. The Analyst Piper Jaffray's Tyler M....
